Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PA9159 nasal spray in seasonal allergic rhinitis – phase II
CTR20220263Phase 2Completed
- Sponsor
- Anhui Platuo Pharmaceutical Technology
- Start
- Feb 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pa9159 in seasonal allergic rhinitis (SAR), perennial rhinitis, sponsored by Anhui Platuo Pharmaceutical Technology. Started Feb 2022; status: completed.
02
Drugs
pa9159
03
Conditions
seasonal allergic rhinitis (SAR)perennial rhinitis
Beyond the preview
Go deeper on CTR20220263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220263.